Expand ROIV Menu
ROIV MENU

ROIV Stock Summary and Trading Ideas (Roivant Sciences Ltd. - Common Shares | NASDAQ:ROIV)

Charts for Today's Stock Price and Implied Volatility in Roivant Sciences Ltd. - Common Shares

2-Oct-2026

Stock Price & Volume | Full Chart

30-Day Implied Volatility | IV30 Full Chart

Trade Ideas for Best Option Strategies for ROIV by Theoretical Edge and Win Rates

Sentiment

News

Arbutus gains on plans to buy back 46M shares in tender offer

Seeking Alpha News (Wed, 30-Sep 12:51 PM ET)

Trading Statistics

Key Ratios

Roivant Sciences Ltd. - Common Shares (ROIV) Frequently Asked Questions

What does Roivant Sciences Ltd. - Common Shares do?

Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.

What symbol and exchange does Roivant Sciences Ltd. - Common Shares shares trade?

Roivant Sciences Ltd. - Common Shares trades on the NASDAQ stock market under the symbol ROIV.

What is Roivant Sciences Ltd. - Common Shares stock price doing today?

As of October 2, 2026, ROIV stock price climbed to $35.72 with 4,153,817 million shares trading.

What is Roivant Sciences Ltd. - Common Shares's Beta?

ROIV has a beta of 0.56, meaning it tends to be less sensitive to market movements. ROIV has a correlation of 0.03 to the broad based SPY ETF.

How much is Roivant Sciences Ltd. - Common Shares worth?

ROIV has a market cap of $25.80 billion. This is considered a Large Cap stock.

How much money does Roivant Sciences Ltd. - Common Shares make?

Last quarter Roivant Sciences Ltd. - Common Shares reported $1 million in Revenue and -$.34 earnings per share. This fell short of revenue expectation by $-903,840 and exceeded earnings estimates by $.03.

What is the highest and lowest price Roivant Sciences Ltd. - Common Shares traded in the last 3 year period?

In the last 3 years, ROIV traded as high as $42.50 and as low as $8.25.

What are the top ETFs holding Roivant Sciences Ltd. - Common Shares?

The top ETF exchange traded funds that ROIV belongs to (by Net Assets): IJH, VTI, VB, XMMO, VBK.

Is Roivant Sciences Ltd. - Common Shares (ROIV) a good investment?

ROIV has outperformed the market in the last year with a return of +123.5%, while the SPY ETF gained +16.1%. However, in the most recent history, ROIV shares have underperformed the stock market with its stock returning +1.7% in the last 3 month period and -10.2% for the last 2 week period, while SPY has returned +3.6% and +1.0%, respectively.

What are the support and resistance levels for Roivant Sciences Ltd. - Common Shares (ROIV)?

ROIV support price is $34.63 and resistance is $36.37 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ROIV shares will trade within this expected range on the day.

Market Data Delayed 15 Minutes